EYEN EYENOVIA INC Company Mergers 8-K Filing 2025 - Business Combination On March 18, 2025, Eyenovia Inc. signed a non-binding letter of intent for a reverse merger with Betaliq, Inc., where Betaliq's shareholders would own approximately 83.7% of the combined company, valuing Betaliq at $77 million and Eyenovia at $15 million.Get access to all SEC 8-K filings of the EYENOVIA INC